Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
Abstract
Background: Idiopathic polypoidal choroidal vasculopathy (IPCV) is a disease of choroidal vasculature resulting in idiopathic exudative and or haemorrhagic disorder of the macula. Its end point is subretinal fibrosis that is associated with severe ocular morbidity.1-4 The aim of this article is to provide a basic and current information on IPCV.
Methods: The Internet was searched in English with Google Scholars, Hinari and Elsevier’s Scopus for key words such as idiopathic polypoidal choroidal vasculopathy, update, latest discovery and new treatment options.
Results: Twelve recent and relevant peer reviewed articles were downloaded after an internet search.
References
Management of Polypoidal Choroidal Vasculopathy: Expert Consensus in Taiwan. Chen LJ, Cheng CK, Yeung L, Yang CH, Cheng SJ, Taiwan PCV Consensus Group. J Formosan Med Ass 2020; 119: 569-576.
Imanmura Y. Polypoidal Choroidal Vasculopathy: A Review. SurvOphthalmol 2010; 55: 501–515.
Yannuzzi LA, Ciardella A, Spaide RF, Rabb M, Freund KB, Orlock DA. The expanding clinical spectrum of idiopathic polypoidal choroidal
vasculopathy. Arch Ophthalmol 1997; 115: 478– 485.
NakashizukaH, Mitsumata M, OKisaka S, Shimada H, Kawamura A, Mori R, et al.
Clinicopathologic Findings in Polypoidal Choroidal Vasculopathy. Invest Ophthalmol Vis Sci 2008; 49:4729–4737.
Balaratnasingam C, Lee WK, Koizumi H, Dansingani K, Inoue M. Polypoidal Choroidal Vasculopathy: A Distinct Disease or
Manifestation of Many? Retina 2016; 36: 1-8.
Atul K, Devesh K, Dheepak SM, Meghal G, Barkha G, Prakhyat R, et al. Polypoidal choroidal vasculopathy: a comprehensive clinical update.
Ther Adv Ophthalmol 2019;11: 1–26.
Bo Q, Yan Q, Shen M, Song M, Sun M. Appearance of Polypoidal Lesions in Patients with Polypoidal Choroidal Vasculopathy Using
Swept-Source Optical Coherence Tomographic Angiography. JAMA Ophthalmol 2019; 137: 642- 650.
Yadav S, Parry DG, Beare NV. Polypoidal choroidal vasculopathy: a common type of neovascular age-related macular degeneration
in Caucasians. Br J Ophthalmol 2017; 101: 1377– 1380.
Cheng CK, Peng CH, Chang CK, Hu CC, Chen LJ. One-year outcomes of intravitreal bevacizumab (avastin) therapy for polypoidal choroidal vasculopathy. Retina 2011; 31: 846- 856.
Anantharaman G, Sheth J, Bhende M, Narayanan R, Natarajan S, Rajendran A, et al. Polypoidal choroidal vasculopathy: Pearls in
diagnosis and management. Indian J Ophthalmol 2018; 66:896-908.
Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y. Polypoidal Choroidal Vasculopathy: Definition, Pathogenesis, Diagnosis, and
Management. Ophthalmology 2018; 125: 708- 724.
Coscas G, Lupidi M, Coscas F. Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of
age-related macular degeneration. Invest Ophthalmol Vis Sci 2015; 56: 3187–3195.
